| Product Name | CAS No. | Available Types | Remarks |
| 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone | 179688-29-0 | Erlotinib intermediate | for R&D or no patent covered area use only |
| 4-Chloro-6,7-di(2-methoxyethoxy)quinazoline | 183322-18-1 | Erlotinib intermediate | for R&D or no patent covered area use only |
| trans-4-dimethylaminocrotonic acid hydrochloride | 848133-35-7 | Afatinib intermediate | for R&D or no patent covered area use only |
| 1-Cyclopropylnaphthalene | 25033-19-6 | Afatinib intermediate | for R&D or no patent covered area use only |
| (s)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 | Afatinib intermediate | for R&D or no patent covered area use only |
| 7-Fluoro-6-nitro-4-hydroxyquinazoline | 162012-69-3 | Afatinib intermediate | for R&D or no patent covered area use only |
| 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid | 137281-39-1 | Pemetrexed Disodium intermediate | for R&D or no patent covered area use only |
| 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic Acid Methyl Ester | 155405-80-4 | Pemetrexed Disodium intermediate | for R&D or no patent covered area use only |
| Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate | 174072-89-0 | Relugolix intermediate | for R&D or no patent covered area use only |
| 3-Amino-6-Methoxypyridazine | 7252-84-8 | Relugolix intermediate | for R&D or no patent covered area use only |
| (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | 886230-77-9 | Axitinib intermediate | for R&D or no patent covered area use only |
| (E)-3-[2-(Pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine | 886230-76-8 | Axitinib intermediate | for R&D or no patent covered area use only |
| 2-Mercapto-N-methylbenzamide | 20054-45-9 | Axitinib intermediate | for R&D or no patent covered area use only |
| (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | 477600-70-7 | Tofacitinib Citrate intermediate | for R&D or no patent covered area use only |
| 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 | Tofacitinib Citrate intermediate | for R&D or no patent covered area use only |
| 1-Benzyl-4-methylpiperidin-3-one | 32018-96-5 | Tofacitinib Citrate intermediate | for R&D or no patent covered area use only |
| Methyl 2-(bromomethyl)-3-nitrobenzoate | 98475-07-1 | Lenalidomide intermediate | for R&D or no patent covered area use only |
| 3-Amino-2,6-piperidinedione hydrochloride | 24666-56-6 | Lenalidomide intermediate | for R&D or no patent covered area use only |
| (tetrahydro-2H-Pyran-4-yl)methanamine | 130290-79-8 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| 4-Chloro-3-nitrobenzenesulfonamide | 97-09-6 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| 1H-Pyrrolo[2,3-b]pyridin-5-ol | 98549-88-3 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| tert-Butyl 4-bromo-2-fluorobenzoate | 889858-12-2 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| 4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde | 1228837-05-5 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| 3,3-Dimethylcyclohexanone | 2979-19-3 | Venetoclax Intermediates | for R&D or no patent covered area use only |
| 5-Fluoro-1,3-dihydro-indol-2-one | 56341-41-4 | Sunitinib intermediate | for R&D or no patent covered area use only |
| 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylamino-ethyl)-amide | 356068-86-5 | Sunitinib intermediate | for R&D or no patent covered area use only |
| 5-Amino-2-chlorobenzotrifluoride | 320-98-4 | Sorafenib intermediate | for R&D or no patent covered area use only |
| 4-(4-Aminophenoxy)-N-methylpicolinamide | 284462-37-9 | Sorafenib intermediate | for R&D or no patent covered area use only |
| Pharma Intermediates |
Copyright© 2010-2025 CHANGZHOU ELITE UNION INT'L COMPANY(-EUIC-) All Rights Reserved.
